Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Changes in Stockholders??? Equity (Unaudited)

v3.24.3
Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   8,009,743    
Beginning balance at Dec. 31, 2022 $ 2,374 $ 1 $ 24,559 $ (22,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 2,021   2,021  
Sale of Common Stock under ATM, net of issuance costs (in shares)   17,872,955    
Sale of Common Stock under ATM, net of issuance costs 24,764 $ 2 24,762  
Stock issuance upon exercise of stock options (in shares)   180,072    
Stock issuance upon exercise of stock options 214   214  
Stock issuance upon vesting of restricted stock units (in shares)   255,220    
Stock issuance upon exercise of warrants (in shares)   7,292    
Stock issuance upon exercise of warrants 16   16  
Net loss (10,760)     (10,760)
Ending balance (in shares) at Sep. 30, 2023   26,325,282    
Ending balance at Sep. 30, 2023 18,629 $ 3 51,572 (32,946)
Beginning balance (in shares) at Jun. 30, 2023   25,990,516    
Beginning balance at Jun. 30, 2023 21,062 $ 3 50,535 (29,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 926   926  
Stock issuance upon exercise of stock options (in shares)   92,046    
Stock issuance upon exercise of stock options 111   111  
Stock issuance upon vesting of restricted stock units (in shares)   242,720    
Net loss (3,470)     (3,470)
Ending balance (in shares) at Sep. 30, 2023   26,325,282    
Ending balance at Sep. 30, 2023 $ 18,629 $ 3 51,572 (32,946)
Beginning balance (in shares) at Dec. 31, 2023 26,329,032 26,329,032    
Beginning balance at Dec. 31, 2023 $ 15,937 $ 3 52,759 (36,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 3,300   3,300  
Sale of Common Stock under ATM, net of issuance costs (in shares)   50,000    
Sale of Common Stock under ATM, net of issuance costs $ 76   76  
Stock issuance upon exercise of stock options (in shares) 38,069 38,069    
Stock issuance upon exercise of stock options $ 29   29  
Stock issuance upon vesting of restricted stock units (in shares)   177,827    
Net loss $ (14,541)     (14,541)
Ending balance (in shares) at Sep. 30, 2024 26,594,928 26,594,928    
Ending balance at Sep. 30, 2024 $ 4,801 $ 3 56,164 (51,366)
Beginning balance (in shares) at Jun. 30, 2024   26,562,111    
Beginning balance at Jun. 30, 2024 8,706 $ 3 55,090 (46,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock based compensation expense 1,053   1,053  
Stock issuance upon exercise of stock options (in shares)   32,817    
Stock issuance upon exercise of stock options 21   21  
Net loss $ (4,979)     (4,979)
Ending balance (in shares) at Sep. 30, 2024 26,594,928 26,594,928    
Ending balance at Sep. 30, 2024 $ 4,801 $ 3 $ 56,164 $ (51,366)